NCT03429556 - Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 8, 2018

Primary Completion Date

July 10, 2018

Study Completion Date

July 10, 2018

Conditions

Abdominoplasty

Interventions

BIOLOGICAL

Botulinum Neurotoxin Serotype E

Single botulinum neurotoxin serotype E injection into RA muscles during abdominoplasty surgery.

DRUG

Placebo

Placebo (sterile saline solution 0.9% Sodium Chloride Injection) injected into RA muscles during abdominoplasty surgery.

Trial Locations (2)

Huntington Ambulatory Surgery Center, Pasadena

Lotus Clinical Research, LLC, Pasadena